FDA Clearance Tracker · P010013-S047
NOVASURE IMPEDANCE CONTROLLED ENDOMETRIAL ABLATION SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 25, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Apr 25, 2014
Approved
Time to decision
273 days
Received Jul 26, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010013-S047
- Device name
- NOVASURE IMPEDANCE CONTROLLED ENDOMETRIAL ABLATION SYSTEM
- Applicant
- Hologic, Inc.
- Applicant location
- Malborough, MA
- Received
- Jul 26, 2013
- Decided
- Apr 25, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P010013
Device type
- Device type
- Device, thermal ablation, endometrial (MNB)
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR DECREASED OUTER SHEATH DIAMETER, MODIFICATION OF THE CERVICAL SEAL DESIGN, AND CHANGE IN THE FRONT HANDLE COLOR.
Source documents
Other decisions for Hologic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- I-View®510(k)
K254090 · Decided Sep 2, 2026 · 257 days after receipt
Device type: Full Field Digital, System, X-Ray, Mammographic (MUE) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.